儿童多发性硬化症：当前和新兴概念。
Multiple Sclerosis in Children: Current and Emerging Concepts.
机构信息
Department of Neurology, University of Virginia, Charlottesville, Virginia.
Department of Pediatrics, University of Colorado, Aurora, Colorado.
出版信息
Semin Neurol. 2020 Apr;40(2):192-200. doi: 10.1055/s-0040-1703000. Epub 2020 Apr 15.
Abstract
Multiple sclerosis is being increasingly recognized and diagnosed in children. In the past several years, advances have been made in diagnosing multiple sclerosis in children, identifying new genetic and environmental risk factors, delineating underlying immunobiology, characterizing imaging findings, and implementing new treatment strategies. In this review, we discuss these advances. Future research into the determinants of multiple sclerosis in children and into new treatment options will be aided by continued international collaboration.
摘要
多发性硬化症在儿童中越来越被认识和诊断。在过去的几年中，儿童多发性硬化症的诊断、新的遗传和环境风险因素的识别、潜在免疫生物学的描述、影像学表现的特征以及新的治疗策略的实施都取得了进展。在这篇综述中，我们讨论了这些进展。对儿童多发性硬化症决定因素和新治疗选择的未来研究将得益于持续的国际合作。
相似文献
1
Multiple Sclerosis in Children: Current and Emerging Concepts.儿童多发性硬化症：当前和新兴概念。
Semin Neurol. 2020 Apr;40(2):192-200. doi: 10.1055/s-0040-1703000. Epub 2020 Apr 15.
2
Pediatric multiple sclerosis: updates in epidemiology, clinical features and management.小儿多发性硬化症：流行病学、临床特征及管理的最新进展
Neurodegener Dis Manag. 2016 Dec;6(6s):3-7. doi: 10.2217/nmt-2016-0046.
3
Pediatric multiple sclerosis.小儿多发性硬化症。
Nat Rev Neurol. 2009 Nov;5(11):621-31. doi: 10.1038/nrneurol.2009.158. Epub 2009 Oct 13.
4
Multiple sclerosis: new concepts of pathogenesis, diagnosis, and treatment.多发性硬化症：发病机制、诊断和治疗的新概念
Compr Ther. 1989 Mar;15(3):39-44.
5
MS Forum Workshop: looking ahead: advances in multiple sclerosis in the next decade.多发性硬化症论坛研讨会：展望未来十年多发性硬化症的进展
Int MS J. 2009 Jun;16(2):67-70.
6
Multiple sclerosis in children: clinical, diagnostic, and therapeutic aspects.儿童多发性硬化症：临床、诊断及治疗方面
Int Rev Neurobiol. 2007;79:269-79. doi: 10.1016/S0074-7742(07)79011-6.
7
Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.儿童多发性硬化症：临床诊断、治疗策略和研究的最新进展。
Lancet Neurol. 2014 Sep;13(9):936-48. doi: 10.1016/S1474-4422(14)70093-6.
8
Modern approaches to multiple sclerosis.多发性硬化症的现代治疗方法。
Clin Med (Lond). 2011 Aug;11(4):361-3. doi: 10.7861/clinmedicine.11-4-361.
9
A current understanding of multiple sclerosis.多发性硬化症的当前认识。
JAAPA. 2020 Feb;33(2):19-23. doi: 10.1097/01.JAA.0000651716.72042.21.
10
[Future challenges in multiple sclerosis].[多发性硬化症的未来挑战]
Med Clin (Barc). 2014 Dec;143 Suppl 3:44-7. doi: 10.1016/S0025-7753(15)30010-5.
引用本文的文献
1
Respiratory functions, respiratory muscle strength and fatigue in patients with pediatric-onset multiple sclerosis: a comparative cross-sectional study.儿童期多发性硬化症患者的呼吸功能、呼吸肌力量和疲劳：一项比较性横断面研究。
Acta Neurol Belg. 2025 Feb;125(1):69-75. doi: 10.1007/s13760-024-02628-4. Epub 2024 Aug 21.
2
Changes of Target Essential Trace Elements in Multiple Sclerosis: A Systematic Review and Meta-Analysis.多发性硬化症中靶标必需微量元素的变化：系统评价与荟萃分析
Biomedicines. 2024 Jul 17;12(7):1589. doi: 10.3390/biomedicines12071589.
3
Ultrastructural Characterization of PBMCs and Extracellular Vesicles in Multiple Sclerosis: A Pilot Study.多发性硬化症患者外周血单核细胞和细胞外囊泡的超微结构特征：一项初步研究。
Int J Mol Sci. 2024 Jun 22;25(13):6867. doi: 10.3390/ijms25136867.
4
Pediatric traumatic brain injury and early age multiple sclerosis in Finland: A nationwide register-based cohort study.芬兰儿科创伤性脑损伤与早发性多发性硬化症：一项基于全国登记的队列研究。
Brain Behav. 2024 Apr;14(4):e3478. doi: 10.1002/brb3.3478.
5
Multiple sclerosis under the age of ten: the challenge of a rare diagnosis in a special population - a case series.10岁以下的多发性硬化症：特殊人群中罕见诊断的挑战——病例系列
Front Neurosci. 2023 Dec 20;17:1297171. doi: 10.3389/fnins.2023.1297171. eCollection 2023.
6
Phase-sensitive T1 inversion recovery imaging and its impact on the detection of cortical demyelinating lesions in patients with multiple sclerosis.相敏T1反转恢复成像及其对多发性硬化症患者皮质脱髓鞘病变检测的影响。
Radiol Bras. 2023 Jul-Aug;56(4):IX. doi: 10.1590/0100-3984.2023.56.4e3.
7
Pediatric Multiple Sclerosis: Changing the Trajectory of Progression.小儿多发性硬化症：改变疾病进展轨迹。
Curr Neurol Neurosci Rep. 2023 Nov;23(11):657-669. doi: 10.1007/s11910-023-01300-3. Epub 2023 Oct 4.
8
Interim guidelines for the assessment and treatment of pain in children with multiple sclerosis.多发性硬化症患儿疼痛评估与治疗的临时指南。
Front Neurosci. 2023 Sep 14;17:1235945. doi: 10.3389/fnins.2023.1235945. eCollection 2023.
9
Clinical predictors of NEDA-3 one year after diagnosis of pediatric multiple sclerosis: an exploratory single-center study.儿童多发性硬化症诊断后一年达到无疾病活动状态3（NEDA-3）的临床预测因素：一项探索性单中心研究
Front Neurosci. 2023 Sep 14;17:1259306. doi: 10.3389/fnins.2023.1259306. eCollection 2023.
10
Self-management interventions for people with multiple sclerosis: A systematic review and meta-analysis protocol.针对多发性硬化症患者的自我管理干预措施：一项系统评价与荟萃分析方案
Health Sci Rep. 2023 Sep 4;6(9):e1536. doi: 10.1002/hsr2.1536. eCollection 2023 Sep.
本文引用的文献
1
Body mass index trajectories in pediatric multiple sclerosis.儿童多发性硬化症的体重指数轨迹。
Dev Med Child Neurol. 2019 Nov;61(11):1289-1294. doi: 10.1111/dmcn.14233. Epub 2019 Apr 5.
2
Childhood multiple sclerosis is associated with reduced brain volumes at first clinical presentation and brain growth failure.儿童多发性硬化症与首次临床发作时的脑容量减少和脑生长失败有关。
Mult Scler. 2019 Jun;25(7):927-936. doi: 10.1177/1352458519829698. Epub 2019 Apr 4.
3
Dynamic gray matter volume changes in pediatric multiple sclerosis: A 3.5 year MRI study.儿童多发性硬化症的动态灰质体积变化：一项为期 3.5 年的 MRI 研究。
Neurology. 2019 Apr 9;92(15):e1709-e1723. doi: 10.1212/WNL.0000000000007267. Epub 2019 Mar 13.
4
Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry.混合映射揭示了遗传背景对多发性硬化症风险的差异影响。
PLoS Genet. 2019 Jan 17;15(1):e1007808. doi: 10.1371/journal.pgen.1007808. eCollection 2019 Jan.
5
Puberty onset and pediatric multiple sclerosis activity in boys.男孩青春期起始与小儿多发性硬化症活动。
Mult Scler Relat Disord. 2019 Jan;27:184-187. doi: 10.1016/j.msard.2018.10.014. Epub 2018 Oct 22.
6
Heterogeneity in association of remote herpesvirus infections and pediatric MS.远程疱疹病毒感染与儿童多发性硬化症关联的异质性。
Ann Clin Transl Neurol. 2018 Sep 17;5(10):1222-1228. doi: 10.1002/acn3.636. eCollection 2018 Oct.
7
Urban air quality and associations with pediatric multiple sclerosis.城市空气质量及其与儿童多发性硬化症的关联。
Ann Clin Transl Neurol. 2018 Sep 27;5(10):1146-1153. doi: 10.1002/acn3.616. eCollection 2018 Oct.
8
Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US.美国儿科多发性硬化症中新型疾病修正疗法的应用。
Neurology. 2018 Nov 6;91(19):e1778-e1787. doi: 10.1212/WNL.0000000000006471. Epub 2018 Oct 17.
9
Incidence and prevalence of MS in children: A population-based study in Ontario, Canada.儿童多发性硬化症的发病率和患病率：加拿大安大略省的一项基于人群的研究。
Neurology. 2018 Oct 23;91(17):e1579-e1590. doi: 10.1212/WNL.0000000000006395. Epub 2018 Sep 26.
10
Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis.芬戈莫德与干扰素β-1a 在儿科多发性硬化症中的对比试验。
N Engl J Med. 2018 Sep 13;379(11):1017-1027. doi: 10.1056/NEJMoa1800149.
Zotero 插件